Mersana Therapeutics Inc (MRSN) — Cash Flow Reinvestment Rate
Mersana Therapeutics Inc (MRSN) has a Cash Flow Reinvestment Rate of 0.30x as of September 2022, reinvesting $16.49 Million (capex $426.00K plus investments $-16.07 Million) from operating cash flow of $54.60 Million. Explore capital reinvestment ratio of Mersana Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Mersana Therapeutics Inc Cash Flow Reinvestment Rate (2016–2016)
Historical reinvestment intensity for Mersana Therapeutics Inc across 1 annual periods. Also explore MRSN total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Mersana Therapeutics Inc (2016–2016)
Year-by-year capital reinvestment analysis for Mersana Therapeutics Inc. For live market cap and broader valuation context, see how much is Mersana Therapeutics Inc worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.07x | $2.17 Million | $31.59 Million | $1.08 Million | — |